Skip to main content
SpringerLink
Log in

Should women with diabetic nephropathy considering pregnancy continue ACE inhibitor or angiotensin II receptor blocker therapy until pregnancy is confirmed?

  • Letter
  • Published:
Diabetologia Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abbreviations

ACEI:

ACE inhibitor

ARB:

Angiotensin II receptor blocker

References

  1. Tennant PWG, Glinianaia SV, Bilous RW, Rankin J, Bell R (2014) Pre-existing diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: a population-based study. Diabetologia 57:285–294

    Article  CAS  PubMed  Google Scholar 

  2. Bullo M, Tschumi S, Bucher BS, Bianchetti MG, Simonetti GD (2012) Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review. Hypertension 60:444–450

    Article  CAS  PubMed  Google Scholar 

  3. Cooper WO, Hernandez-Diaz S, Arbogast PG et al (2006) Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354:2443–2451

    Article  CAS  PubMed  Google Scholar 

  4. Polifka JE (2012) Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence. Birth Defects Res A Clin Mol Teratol 94:576–598

    Article  CAS  PubMed  Google Scholar 

  5. Porta M, Hainer JW, Jansson SO et al (2011) Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled diabetic retinopahty candesartan trials. Diabetologia 54:1298–1303

    Article  CAS  PubMed  Google Scholar 

  6. Mathiesen EM, Ringholm L, Feldt-Rasmussen B, Clausen P, Damm P (2012) Obstetric nephrology: pregnancy in women with diabetic nephropathy—the role of antihypertensive treatment. Clin J Am Soc Nephrol 7:2081–2088

    Article  CAS  PubMed  Google Scholar 

  7. Nielsen LR, Damm P, Mathiesen ER (2009) Improved pregnancy outcome in type 1 diabetic women with microalbuminuria or diabetic nephropathy: effect of intensified antihypertensive therapy? Diabetes Care 32:38–44

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Bar J, Chen R, Schoenfeld A et al (1999) Pregnancy outcome in patients with insulin dependent diabetes mellitus and diabetic nephropathy treated with ACE inhibitors before pregnancy. J Pediatr Endocrinol Metab 12:659–665

    Article  CAS  PubMed  Google Scholar 

Download references

Duality of interest

The authors declare that there is no duality of interest associated with this manuscript.

Contribution statement

Both authors conceived and wrote the article, revised it and have approved the final version for publication.

Author information

Authors and Affiliations

  1. Regional Nephrology Unit, Belfast City Hospital, 51 Lisburn Road, Belfast, BT9 7AB, UK

    Gareth Lewis & Alexander P. Maxwell

Authors
  1. Gareth Lewis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alexander P. Maxwell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gareth Lewis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lewis, G., Maxwell, A.P. Should women with diabetic nephropathy considering pregnancy continue ACE inhibitor or angiotensin II receptor blocker therapy until pregnancy is confirmed?. Diabetologia 57, 1082–1083 (2014). https://doi.org/10.1007/s00125-014-3188-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00125-014-3188-x

Keywords

Search

Navigation